Teckro vs IQVIA Scribe

Teckro transforms your clinical trial protocol into a hub of communication and collaboration. It’s a digital platform that connects all study stakeholders with the knowledge they need, when they need it. Drugs from trials powered by Teckro have been granted priority review and approval by regulators in the US and Europe. Thousands of investigators and 20,000+ sites around the world rely on Teckro to execute clinical trials from biopharma sponsors, including 12 out of the Top 20 pharma companies. We support all therapeutic areas, all phases, and any trial model, whether traditional, virtual, or a hybrid approach - if Teckro isn't used on your clinical trial, ask your study manager for it.

IQVIA Scribe is an online/offline application used to capture data directly from patients enrolled in clinical trials. Patients enrolled in a study using Scribe will receive an enrollment notification via email or text with a link to download the application and instructions used to enroll in the study. Relevant questionnaires will be available for completion throughout the duration of the study ++++Scribe amplifies the patient's voice in clinical research by allowing Clinical Outcomes Assessments to be used in more trials. Whether deploying to smartphones, tablets or the web, our Sculptor visual build and deployment tools help automate the eCOA process, giving absolute transparency and greater control to sponsors and CRO’s.